← Mechanisms of action
leukocytes
CELL-LINEHomo sapiens
Drugs acting on this target (15)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| autologous immune cells | Immunity, active | experimental | Cell therapy | leukocytes immunity, active |
| immunepotent-crp | Immunity, active | experimental | Biological | leukocytes immunity, active |
| allogeneic blood cells | Supplementation | experimental | Cell therapy | leukocytes supplementation |
| autologous hematopoietic cells transduced with a lentiviral vector with dclre1c | Supplementation | experimental | Cell therapy | leukocytes supplementation |
| cd25-depleted peripheral blood mononuclear cell | Supplementation | experimental | Cell therapy | leukocytes supplementation |
| ect-001-cb | Supplementation | experimental | Cell therapy | leukocytes supplementation |
| immune cell | Supplementation | experimental | Cell therapy | leukocytes supplementation |
| st-400 | Supplementation | experimental | Cell therapy | leukocytes supplementation |
| umbilical cord blood derived mak immune cells | Supplementation | experimental | Cell therapy | leukocytes supplementation |
| white blood cells | Supplementation | experimental | Cell therapy | leukocytes supplementation |
| cd45-depleted allogenic peripheral blood stem cell | Tissue restoration | experimental | Cell therapy | leukocytes tissue restoration |
| clbs12 | Tissue restoration | experimental | Cell therapy | leukocytes tissue restoration |
| cord blood hematopoietic stem cell | Tissue restoration | experimental | Cell therapy | leukocytes tissue restoration |
| ixmyelocel-t | Tissue restoration | experimental | Cell therapy | leukocytes tissue restoration |
| leukocytes | Tissue restoration | experimental | Cell therapy | leukocytes tissue restoration |